Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bareford

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
British Journal of Biomedical Science|October 4, 2007
Increased levels of soluble P-selectin correlate with iron overload in sickle cell diseaseA D Blann, S S Marwah, A J Cobley, et al.
Vox Sanguinis|January 1, 1990
Post-transfusion thrombocytopenia: its duration in splenic and asplenic individualsS Hart, D Bareford, N Smith, et al.
Journal of Thrombosis and Thrombolysis|December 18, 2007
Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotypeA D Blann, J S Mohan, D Bareford, et al.
British Journal of Haematology|October 7, 2000
Plasma levels of vascular endothelial growth factor (VEGF) in haematological cancersF M Belgore, G Y Lip, D Bareford, et al.
Thrombosis Research|July 30, 2005
Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotypeJ S Mohan, G Y H Lip, D Bareford, et al.
Lancet (London, England)|September 2, 1995
Factor V and factor VIII:V ratio as prognostic indicators in paracetamol poisoningS M Bradberry, M Hart, D Bareford, et al.
Clinical and Laboratory Haematology|January 1, 1988
Laboratory tests for monitoring prophylactic exchange transfusion in pregnancy complicated by sickle cell diseaseA J Keidan, S S Marwah, D Bareford, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 7, 2001
Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factorA D Blann, D Gurney, M Wadley, et al.
Journal of Clinical Pathology|August 29, 2003
Splenic rupture as a consequence of dual malignant pathology: a case reportF J Hoar, S-Y Chan, P S Stonelake, et al.
American Journal of Hematology|June 28, 2001
Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, Flt-1, in haematological cancers: a comparison with breast cancerF M Belgore, G Y Lip, D Bareford, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
British Journal of Biomedical Science|October 4, 2007
Increased levels of soluble P-selectin correlate with iron overload in sickle cell diseaseA D Blann, S S Marwah, A J Cobley, et al.
Vox Sanguinis|January 1, 1990
Post-transfusion thrombocytopenia: its duration in splenic and asplenic individualsS Hart, D Bareford, N Smith, et al.
Journal of Thrombosis and Thrombolysis|December 18, 2007
Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotypeA D Blann, J S Mohan, D Bareford, et al.
British Journal of Haematology|October 7, 2000
Plasma levels of vascular endothelial growth factor (VEGF) in haematological cancersF M Belgore, G Y Lip, D Bareford, et al.
Thrombosis Research|July 30, 2005
Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotypeJ S Mohan, G Y H Lip, D Bareford, et al.
Lancet (London, England)|September 2, 1995
Factor V and factor VIII:V ratio as prognostic indicators in paracetamol poisoningS M Bradberry, M Hart, D Bareford, et al.
Clinical and Laboratory Haematology|January 1, 1988
Laboratory tests for monitoring prophylactic exchange transfusion in pregnancy complicated by sickle cell diseaseA J Keidan, S S Marwah, D Bareford, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 7, 2001
Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factorA D Blann, D Gurney, M Wadley, et al.
Journal of Clinical Pathology|August 29, 2003
Splenic rupture as a consequence of dual malignant pathology: a case reportF J Hoar, S-Y Chan, P S Stonelake, et al.
American Journal of Hematology|June 28, 2001
Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, Flt-1, in haematological cancers: a comparison with breast cancerF M Belgore, G Y Lip, D Bareford, et al.
Pageof 7